CHICAGO (Reuters) - Walgreen Co
The company, one of the largest U.S. drugstore chain operators, said earnings rose to $572 million, or 58 cents a share, in the third quarter ended May 31 from $561 million, or 56 cents a share, a year earlier.
Analysts on average had forecast 59 cents a share, according to Reuters Estimates.
Walgreen has seen the pace of prescription drug sales slow as the allergy medicine Zyrtec became available without a prescription.
(Reporting by Brad Dorfman; Editing by Lisa Von Ahn)